Alkermes plc (8AK)
FSX
Closed
Aug 25, 2026
Day's Range
41.5452 wk Range
22.00Overview - 8AK - Alkermes plc
Key Statistics
Valuation
Enterprise Value
6.53B
P/E (Trailing)
‪127.96‬
P/E (Forward)
‪32.24‬
PEG Ratio
‪-1.27‬
Price / Sales (TTM)
‪4.11‬
Price / Book
‪4.43‬
EV / EBITDA
‪26.76‬
Profitability
Profit Margin
‪3.96%‬
Operating Margin
‪15.49%‬
Return on Assets
‪4.20%‬
Return on Equity
‪3.85%‬
Ownership
Shares Outstanding
167.76M
Float
154.64M
Held by Insiders
‪1.40%‬
Held by Institutions
‪108.78%‬
Price stats
Beta
‪0.26‬
50-Day Avg
‪43.57‬
200-Day Avg
‪31.44‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - 8AK - Alkermes plc
Peers - 8AK - Alkermes plc
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on FSX.
- 8AKFSXAlkermes plc6.96BMarket Cap+40.78%52-week change127.97P/E (Trailing)‪3.96%‬Profit Margin
- ANLFSXAnalog Devices, Inc.152.94BMarket Cap+29.62%52-week change44.47P/E (Trailing)‪29.78%‬Profit Margin
- PARFSXParker-Hannifin Corporation107.87BMarket Cap+24.53%52-week change35.09P/E (Trailing)‪16.96%‬Profit Margin
- MRKFSXMerck KGaA60.12BMarket Cap+22.72%52-week change23.68P/E (Trailing)‪11.21%‬Profit Margin
- MRKCFSXMerck KGaA – Sponsored ADR59.12BMarket Cap+20.59%52-week change23.25P/E (Trailing)‪11.21%‬Profit Margin
- PY3FSXGalderma Group AG42.67BMarket Cap+18.23%52-week change58.15P/E (Trailing)‪14.57%‬Profit Margin
- H6D0FSXHaleon plc37.44BMarket Cap+2.56%52-week change20.06P/E (Trailing)‪14.55%‬Profit Margin
Profile Summary - 8AK - Alkermes plc
About
Alkermes plc is an Ireland-based, fully integrated global biopharmaceutical company focused on developing and commercializing innovative medicines in neuroscience. It specializes in treatments for serious mental illnesses, addiction, schizophrenia, bipolar I disorder, alcohol and opioid dependence, and sleep disorders…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
